Trademark Overview
On Monday, March 4, 2024, a trademark application was filed for TETRAVECTA with the United States Patent and Trademark Office. The USPTO has given the TETRAVECTA trademark a serial number of 98432248. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 25, 2024. This trademark is owned by Oxford BioMedica Plc. The TETRAVECTA trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacture of products relating to biotechnology; manufacture of gene and cell-based therapy products, viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations and biopharmaceutical products; biotechnology contract manufacturing services; contract manufacturing services of gene and cell-based therapy products, viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations and biopharmaceutical products; contract manufacturing services of technology for biopharmaceutical products and gene and cell-based products; contract manufacturing services of technology for viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations
Research and laboratory analytic and diagnostic services; design of manufacturing facilities; quality control and validation services; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; laboratory services; research and development services; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research; industrial analysis services; provision of information relating to scientific research; provision of scientific information; research and scientific analysis relating to drug discovery and development for others; scientific advisory services; scientific consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; issuing of scientific information; advisory services relating to scientific and clinical research...
